Machine learning classifier accelerates the development of cellular immunotherapies
Making a personalised T cell therapy for cancer patients currently takes at least six months;…
Making a personalised T cell therapy for cancer patients currently takes at least six months;…
Numerous anti-cancer drugs function by targeting the DNA within cancerous cells, halting their proliferation. Yet,…
The Oncology Podcast, part of The Oncology Network, is proud to present the return of The OJC Meets: sister series…
Researchers at the Johns Hopkins Kimmel Cancer Center and the Department of Gynecology and Obstetrics…
A newly developed “GPS nanoparticle” injected intravenously can home in on cancer cells to deliver…
A new study from experts at the University of Exeter, UK, has found that a…
Male breast cancer has distinct alterations in the tumour genome that may suggest potential treatment…
One of the first global studies of young-onset pancreatic cancer (YOPC) rates in the 15-49…
People who have had a kidney transplant are at high risk for developing skin cancers.…
The Oncology Network is proud to produce this episode of The Oncology Journal Club podcast with you.…